Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum

Jochem B. Buil; Roger J.M. Brüggemann; Roeland E. Wasmann; Jan Zoll; Jacques F. Meis; Willem J.G. Melchers; Johan W. Mouton; Paul E. Verweij

doi:10.1093/jac/dkx425

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum

Jochem B. Buil
, Roger J.M. Brüggemann
, Roeland E. Wasmann
, Jan Zoll
, Jacques F. Meis
, Willem J.G. Melchers
, Johan W. Mouton
, Paul E. Verweij

Group Tissing

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

3 Citaten (Scopus)

Samenvatting

In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.

Originele taal-2	Engels
Artikelnummer	dkx425
Pagina's (van-tot)	263
Aantal pagina's	1
Tijdschrift	Journal of Antimicrobial Chemotherapy
Volume	73
Nummer van het tijdschrift	1
DOI's	https://doi.org/10.1093/jac/dkx425
Status	Gepubliceerd - 1 jan 2018

Toegang tot document

10.1093/jac/dkx425

Citeer dit

Buil, J. B., Brüggemann, R. J. M., Wasmann, R. E., Zoll, J., Meis, J. F., Melchers, W. J. G., Mouton, J. W., & Verweij, P. E. (2018). Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum. Journal of Antimicrobial Chemotherapy, 73(1), 263. Artikel dkx425. https://doi.org/10.1093/jac/dkx425

@article{d10a1dae96744d9099edc02b99d2cd58,

title = "Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum",

abstract = "In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.",

author = "Buil, \{Jochem B.\} and Br{\"u}ggemann, \{Roger J.M.\} and Wasmann, \{Roeland E.\} and Jan Zoll and Meis, \{Jacques F.\} and Melchers, \{Willem J.G.\} and Mouton, \{Johan W.\} and Verweij, \{Paul E.\}",

year = "2018",

month = jan,

day = "1",

doi = "10.1093/jac/dkx425",

language = "English",

volume = "73",

pages = "263",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "1",

}

Buil, JB, Brüggemann, RJM, Wasmann, RE, Zoll, J, Meis, JF, Melchers, WJG, Mouton, JW & Verweij, PE 2018, 'Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum', Journal of Antimicrobial Chemotherapy, vol. 73, nr. 1, dkx425, blz. 263. https://doi.org/10.1093/jac/dkx425

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum. / Buil, Jochem B.; Brüggemann, Roger J.M.; Wasmann, Roeland E. et al.
In: Journal of Antimicrobial Chemotherapy, Vol. 73, Nr. 1, dkx425, 01.01.2018, blz. 263.

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

TY - JOUR

T1 - Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs

T2 - Erratum

AU - Buil, Jochem B.

AU - Brüggemann, Roger J.M.

AU - Wasmann, Roeland E.

AU - Zoll, Jan

AU - Meis, Jacques F.

AU - Melchers, Willem J.G.

AU - Mouton, Johan W.

AU - Verweij, Paul E.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.

AB - In the original published version of this article, the drug name isavuconazole appeared incorrectly as isafluconazole in the running head of the article and the title of Figure 1. These errors have now been corrected.

UR - https://www.scopus.com/pages/publications/85040554974

U2 - 10.1093/jac/dkx425

DO - 10.1093/jac/dkx425

M3 - Comment/debate

C2 - 29112717

AN - SCOPUS:85040554974

SN - 0305-7453

VL - 73

SP - 263

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 1

M1 - dkx425

ER -

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs: Erratum

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit